Aberrant hypomethylation of the cancer - Testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia

Annals of Hematology

Volumn 87, Issue 10, 2008, Pages 809-818

  Ortmann, Christina A ^a   Eisele, Lewin ^a   Nückel, Holger ^a   Klein Hitpass, Ludger ^a   Führer, Anja ^a   Dührsen, Ulrich ^a   Zeschnigk, Michael ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

AML; Bisulfite; Cancer testis antigen; Epigenetic; Hypomethylation; Methylation; PRAME

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CANCER TESTIS ANTIGEN; GENOMIC DNA; MESSENGER RNA; PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTRON; MALE; MICROARRAY ANALYSIS; MONONUCLEAR CELL; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; UPREGULATION;

ANTIGENS, NEOPLASM; CELL LINE, TUMOR; DNA METHYLATION; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, MYELOID, ACUTE; SURVIVAL RATE;

EID: 50849098153     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0514-8     Document Type: Article

References (42)

1. Berg T, Guo Y, Abdelkarim M, Fliegauf M, Lubbert M (2007) Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines. Leuk Res 31(4):497-506. doi: 10.1016/ j.leukres.2006.08.008
2. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162(1):156-159. doi: 10.1016/0003-2697(87)90021-2
3. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS (1991) Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 19(14):4008. doi: 10.1093/nar/19.14.4008
4. Doolan P, Clynes M, Kennedy S, Mehta JP, Crown J, O'Driscoll L (2007) Prevalence and prognostic and predictive relevance of PRAME in breast cancer. Breast Cancer Res Treat 109:359-365
5. Durig J, Nuckel H, Huttmann A, Kruse E, Holter T, Halfmeyer K et al (2003) Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. Blood 101(7):2748-2755. doi: 10.1182/blood-2002-09-2683
6. Eisele L, Klein-Hitpass L, Chatzimanolis N, Opalka B, Boes T, Seeber S et al (2007) Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia. Acta Haematol 117(1):8-15. doi: 10.1159/000096854
7. Epping MT, Bernards R (2006) A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer. Cancer Res 66(22):10639-10642. doi: 10.1158/0008-5472.CAN-06-2522
8. Epping MT, Wang L, Edel MJ, Carlee L, Hernandez M, Bernards R (2005) The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 122(6):835-847. doi: 10.1016/j.cell.2005.07.003
9. Esteller M (2003) Profiling aberrant DNA methylation in hematologic neoplasms: A view from the tip of the iceberg. Clin Immunol 109(1):80-88. doi: 10.1016/S1521-6616(03)00208-0
10. Flasshove M, Meusers P, Schutte J, Noppeney R, Beelen DW, Sohrab S et al (2000) Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia. Ann Hematol 79(10):533-542. doi: 10.1007/s002770000193
11. Gardiner-Garden M, Frommer M (1987) CpG islands in vertebrate genomes. J Mol Biol 196(2):261-282. doi: 10.1016/0022-2836(87)90689-9
12. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S et al (2004) Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5(10):R80 doi: 10.1186/gb-2004-5-10-r80
13. Goellner S, Steinbach D, Schenk T, Gruhn B, Zintl F, Ramsay E et al (2006) Childhood acute myelogenous leukaemia: Association between PRAME, apoptosis- and MDR-related gene expression. Eur J Cancer 42(16):2807-2814. doi: 10.1016/j.ejca.2006.06.018
14. Greiner J, Ringhoffer M, Simikopinko O, Szmaragowska A, Huebsch S, Maurer U et al (2000) Simultaneous expression of different immunogenic antigens in acute myeloid leukemia. Exp Hematol 28(12):1413-1422. doi: 10.1016/S0301-472X(00)00550-6
15. Greiner J, Ringhoffer M, Taniguchi M, Li L, Schmitt A, Shiku H et al (2004) mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies. Int J Cancer 108(5):704-711. doi: 10.1002/ijc.11623
16. Greiner J, Schmitt M, Li L, Giannopoulos K, Bosch K, Schmitt A et al (2006) Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches. Blood 108(13):4109-4117. doi: 10.1182/blood-2006-01-023127
17. Griffioen M, Kessler JH, Borghi M, van Soest RA, van der Minne CE, Nouta J et al (2006) Detection and functional analysis of CD8+ T cells specific for PRAME: A target for T-cell therapy. Clin Cancer Res 12(10):3130-3136. doi: 10.1158/1078-0432.CCR-05-2578
18. Ikeda H, Matsushita M, Kawakami H (1999) PRAME protein expressed in leukemia cells as a target molecule for immunotherapy. Rinsho Ketsueki 40(6):484-486
19. Irizarry R, Gautier L, Bolstad BM, Miller C, Astrand M, Cope LM, Gentleman R, Gentry J, Halling C, Huber W, MacDonald J, Rubinstein B, Workman C, Zhang J (2006) Affy: Methods for Affymetrix oligonucleotide arrays. R package version 1.12.2. 2006.
20. Jones PA, Laird PW (1999) Cancer epigenetics comes of age. Nat Genet 21(2):163-167 doi: 10.1038/5947
21. Kirkin AF, Dzhandzhugazyan K, Zeuthen J (1998) The immunogenic properties of melanoma-associated antigens recognized by cytotoxic T lymphocytes. Exp Clin Immunogenet 15(1):19-32. doi: 10.1159/000019050
22. Kirkin AF, Dzhandzhugazyan K, Zeuthen J (1998) Melanoma-associated antigens recognized by cytotoxic T lymphocytes. APMIS 106(7):665-679
23. Li L, Giannopoulos K, Reinhardt P, Tabarkiewicz J, Schmitt A, Greiner J et al (2006) Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts. Int J Oncol 28(4):855-861
24. Matsushita M, Ikeda H, Kizaki M, Okamoto S, Ogasawara M, Ikeda Y et al (2001) Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia. Br J Haematol 112(4):916-926. doi: 10.1046/j.1365-2141.2001.02670.x
25. Oberthuer A, Hero B, Spitz R, Berthold F, Fischer M (2004) The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome. Clin Cancer Res 10(13):4307-4313. doi: 10.1158/1078-0432.CCR-03-0813
26. Paydas S, Tanriverdi K, Yavuz S, Disel U, Baslamisli F, Burgut R (2005) PRAME mRNA levels in cases with acute leukemia: Clinical importance and future prospects. Am J Hematol 79(4):257-261. doi: 10.1002/ajh.20425
27. Pellat-Deceunynck C, Mellerin MP, Labarriere N, Jego G, Moreau-Aubry A, Harousseau JL et al (2000) The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells. Eur J Immunol 30(3):803-809. doi: 10.1002/ 1521-4141(200003)30:3<803::AID-IMMU803>3.0.CO;2-P
28. Proto-Siqueira R, Falcao RP, de Souza CA, Ismael SJ, Zago MA (2003) The expression of PRAME in chronic lymphoproliferative disorders. Leuk Res 27(5):393-396. doi: 10.1016/S0145-2126(02)00217-5
29. Radich JP, Dai H, Mao M, Oehler V, Schelter J, Druker B et al (2006) Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci U S A 103(8):2794-2799. doi: 10.1073/pnas.0510423103
30. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Castillejo JA, Navarro G, Jose-Eneriz ES et al (2007) Epigenetic regulation of PRAME gene in chronic myeloid leukemia. Leuk Res 31:1521-1528
31. Schenk T, Stengel S, Goellner S, Steinbach D, Saluz HP (2007) Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies. Genes Chromosomes Cancer 46(9):796-804. doi: 10.1002/gcc.20465
32. Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, Ahmed S et al (2007) Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet 3(10):2023-2036. doi: 10.1371/journal.pgen.0030181
33. Sigalotti L, Fratta E, Coral S, Tanzarella S, Danielli R, Colizzi F et al (2004) Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine. Cancer Res 64(24):9167-9171. doi: 10.1158/0008-5472.CAN-04-1442
34. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ (2005) Cancer/ testis antigens, gametogenesis and cancer. Nat Rev Cancer 5(8):615-625 doi: 10.1038/nrc1669
35. Steinbach D, Hermann J, Viehmann S, Zintl F, Gruhn B (2002) Clinical implications of PRAME gene expression in childhood acute myeloid leukemia. Cancer Genet Cytogenet 133(2):118-123. doi: 10.1016/ S0165-4608(01)00570-2
36. Steinbach D, Schramm A, Eggert A, Onda M, Dawczynski K, Rump A et al (2006) Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia. Clin Cancer Res 12(8):2434-2441. doi: 10.1158/1078-0432.CCR-05-2552
37. Tajeddine N, Gala JL, Louis M, Van Schoor M, Tombal B, Gailly P (2005) Tumor-associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo. Cancer Res 65(16):7348-7355. doi: 10.1158/ 0008-5472.CAN-04-4011
38. Tajeddine N, Millard I, Gailly P, Gala JL (2006) Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia. Clin Chem Lab Med 44(5):548-555. doi: 10.1515/CCLM.2006.106
39. Takai D, Jones PA (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 99(6):3740-3745. doi: 10.1073/pnas.052410099
40. van Baren N, Chambost H, Ferrant A, Michaux L, Ikeda H, Millard I et al (1998) PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells. Br J Haematol 102(5):1376-1379. doi: 10.1046/j.1365-2141.1998.00982.x
41. Willenbrock K, Kuppers R, Renne C, Brune V, Eckerle S, Weidmann E et al (2006) Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. Haematologica 91(5):596-604
42. Zeschnigk M, Schmitz B, Dittrich B, Buiting K, Horsthemke B, Doerfler W (1997) Imprinted segments in the human genome: Different DNA methylation patterns in the Prader-Willi/Angelman syndrome region as determined by the genomic sequencing method. Hum Mol Genet 6(3):387-395. doi: 10.1093/ hmg/6.3.387